Pembrolizumab‐induced interstitial lung disease following thoracic surgery in a patient with non‐small cell lung cancer-Reference-Cited by-同舟云学术

Pembrolizumab‐induced interstitial lung disease following thoracic surgery in a patient with non‐small cell lung cancer

Published:2019-09-11 Issue:11 Volume:10 Page:2179-2182
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Fujita Tetsuo¹^ORCID,Hayama Nami¹,Kuroki Tsuguko¹,Shiraishi Yuka¹,Amano Hiroyuki¹,Nakamura Makoto¹,Hirano Satoshi²,Aramaki Nao³,Ichinose Shuji³,Shimizu Shinichiro⁴,Tabeta Hiroshi¹,Nakamura Sukeyuki¹

Affiliation:

1. Department of RespirologyFunabashi Municipal Medical Center Chiba Japan

2. Department of Medical OncologyFunabashi Municipal Medical Center Chiba Japan

3. Department of Thoracic SurgeryFunabashi Municipal Medical Center Chiba Japan

4. Department of PathologyFunabashi Municipal Medical Center Chiba Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13194

Reference13 articles.

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

2. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

3. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

4. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

5. Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Case of Pleurisy as Immune-related Adverse Events of Neoadjuvant Nivolumab and Chemotherapy After Lobectomy;Haigan;2024-08-20

2. Remitting Seronegative Symmetrical Synovitis with Pitting Edema: A Case Report of an Immune-Related Adverse Event following Surgery;Case Reports in Oncology;2023-08-16

3. Multi‐organs perioperative immune‐related adverse events and postoperative bronchial anastomotic fistula in a patient receiving neoadjuvant immunotherapy with NSCLC;Thoracic Cancer;2022-07-11

4. Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer;General Thoracic and Cardiovascular Surgery;2022-03-19

5. Pembrolizumab induced pneumonitis;Radiopaedia.org;2021-10-06